NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Federica Giugliano
European Institute of Oncology Milan - Milan / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5325217
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Federica Giugliano's MOST POPULAR ARTICLES
1-)
Evolution of low HER2 expression between early and advanced-stage breast cancerP Tarantino, S Gandini, E Nicolò, P Trillo, F Giugliano, P Zagami, ...European Journal of Cancer 163, 35-43, 20221182022
2-)
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectivesE Nicolò, F Giugliano, L Ascione, P Tarantino, C Corti, SM Tolaney, ...Cancer Treatment Reviews 106, 102395, 2022742022
3-)
Bystander effect of antibody–drug conjugates: fact or fiction?F Giugliano, C Corti, P Tarantino, F Michelini, G CuriglianoCurrent oncology reports 24 (7), 809-817, 2022622022
4-)
Antibody–drug conjugates for the treatment of breast cancerC Corti, F Giugliano, E Nicolò, L Ascione, G CuriglianoCancers 13 (12), 2898, 2021572021
5-)
First line treatment of BRAF mutated advanced melanoma: Does one size fit all?F Giugliano, E Crimini, P Tarantino, P Zagami, J Uliano, C Corti, ...Cancer Treatment Reviews 99, 102253, 2021362021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept